Labshake search
Citations for Shenandoah Biotechnology :
1 - 10 of 10 citations for M CSF Rat HEK293 since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Genomics 2020Quote: ... 16.7 ng/ml mouse M-CSF (Shenandoah Biotechnology) was added ...
-
bioRxiv - Neuroscience 2023Quote: ... and mouse M-CSF (Shenandoah Biotechnology, 200-08- 10, 1:1000). Cultures were treated with 100 ng/mL of either IFNγ ...
-
bioRxiv - Immunology 2022Quote: ... and 10% L929 conditioned media (or 10 ng/mL M-CSF; Shenandoah Biotech # 200-08) in T75 flasks.
-
bioRxiv - Cancer Biology 2022Quote: ... and 20 ng/mL GM-CSF (Shenandoah Biotech or Custom Biologics) in 6-well plates (Greinier ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 10 ng/ml GM-CSF (Shenandoah Biotech or Custom Biologics) and 100U/100 μg/mL penicillin/streptomycin (Wisent) ...
-
bioRxiv - Bioengineering 2020Quote: ... 1000 U/mL of Granulocyte-macrophage colony-stimulating factor (GM-CSF) (Shenandoah Biotechnology), and 500 U/mL of IL-4 (Shenandoah Biotechnology) ...
-
bioRxiv - Bioengineering 2022Quote: ... granulocyte-macrophage colony-stimulating factor (GM-CSF) 200-15 (Shenandoah BioTech, Warminster, PA). Mercaptoethanol (Thermofisher) ...
-
bioRxiv - Immunology 2021Quote: ... bone marrow cells were grown in R10 media supplemented with 20 ng/mL mouse recombinant granulocyte-macrophage colony-stimulating factor (“GM-CSF”; 10822-026, Shenandoah Biotechnology). Fresh media was added on days 3 and 6 after plating ...
-
bioRxiv - Biochemistry 2022Quote: ... TF-1 cells were also supplemented with the 2 ng/ml Human Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) (Shenandoah Biotechnology, 100-08). Cells were incubated in a humidified incubator at 37°C with 5% CO2.
-
bioRxiv - Cell Biology 2021Quote: ... cells were washed twice and supplemented either with no cytokines or with human (h) IL-2 (200 ng/ml) and mouse (m) mIL-12 (10 ng/ml) from Shenandoah Biotechnology alone or in combination every three days.